Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Detalles Bibliográficos
Autores principales: Gallagher, Jason C., Morgan, Rebecca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575309/
https://www.ncbi.nlm.nih.gov/pubmed/36257548
http://dx.doi.org/10.1016/j.cmi.2022.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575309/
https://www.ncbi.nlm.nih.gov/pubmed/36257548
http://dx.doi.org/10.1016/j.cmi.2022.10.016

Ejemplares similares